Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00947Fulvestrant1Terminated1
DB11730Ribociclib1Terminated1
DB14892Spartalizumab1Terminated1